FFM
GMAB icon

Forum Financial Management’s Genmab GMAB Stock Holding History

Forum Financial Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,548
Closed -$235K – 633
2022
Q4 		$235K Buy
+5,548
New +$229K 0.01% 485
2022
Q2 		– Sell
-5,542
Closed -$200K – 607
2022
Q1 		$200K Hold
5,542
– – 0.01% 570
2021
Q4 		$219K Buy
+5,542
New +$231K 0.01% 574

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Forum Financial Management's GMAB Position: Q1 2023 in Review

Forum Financial Management sold out of Genmab (GMAB) in Q1 2023, closing a stake of 5,548 shares — an estimated $235K sold.

Forum Financial Management first reported a position in GMAB in Q4 2021 and held it in 3 quarters. The position peaked at $235K in Q4 2022. 216 funds tracked by Wall St. Rank hold GMAB as of Q1 2023.

  • Forum Financial Management reported no remaining Genmab position as of Q1 2023 after selling out during the quarter.
  • Forum Financial Management sold 5,548 Genmab shares in Q1 2023, an estimated $235K.
  • Forum Financial Management first reported a position in Genmab in Q4 2021 and held it in 3 quarters.
  • Forum Financial Management's Genmab position peaked at $235K in Q4 2022.
  • 216 funds tracked by Wall St. Rank held Genmab as of Q1 2023.

Based on Forum Financial Management's 13F filing for Q1 2023, filed 19 Apr 2023.